WASHINGTON (AP) — The Food and Drug Administration says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA gave a court-ordered update on its progress in a legal filing late Wednesday, [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA says its safety review of abortion pill will continue into next year | 0 | 5.97 | 08-10-2026 |
| 2 | An appeals court is considering a push to restrict most common abortion method | 0 | 5.41 | 09-09-2026 |
| 3 | Abortion pill survivors urge Trump admin to stop defending Biden FDA policy | -8 | 4 | 09-07-2026 |
| 4 | Federal Appeals Court Hears Baseless Challenge to the Abortion Pill Mifepristone — Again | 0 | 6.62 | 09-09-2026 |
| 5 | Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 | 0 | 11.66 | 23-01-2026 |
| 6 | Louisiana urges Supreme Court to leave in place order barring mailing of abortion pill | 0 | 4.28 | 07-05-2026 |
| 7 | Мантуров: уведомительный режим маркировки лекарств продлится максимум до конца года | 0 | 0 | 30-10-2020 |
| 8 | Thyroid medication recall classified under FDA's most urgent level | 0 | 6.6 | 23-09-2026 |
| 9 | Thyroid medication recall classified under FDA's most urgent level | 0 | 6.6 | 23-09-2026 |